Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology

• DOI: 10.1093/brain/awm276
• Publication Date: 2007-12-04T01:25:52Z
• Authors: A. Berson; M. Knobloch; M. Hanan; S. Diamant; M. Sharoni; D. Schuppli; B. C. Geyer; R. Ravid; T. S. Mor; R. M. Nitsch; H. Soreq
• Keywords: Adult; Male; 0301 basic medicine; 610 Medicine & health; Mice, Transgenic; Hippocampus; Gene Expression Regulation, Enzymologic; Mice; alternative splicing; 03 medical and health sciences; Alzheimer Disease; Animals; Humans; Alzheimer’s disease; acetylcholinesterase; alternative splicing; b-Amyloid; Aged; Aged, 80 and over; Amyloid beta-Peptides; Dose-Response Relationship, Drug; Brain; 11359 Institute for Regenerative Medicine (IREM); Dendrites; acetylcholinesterase; Middle Aged; 3. Good health; Alternative Splicing; 2728 Neurology (clinical); Astrocytes; Acetylcholinesterase; Female; b-Amyloid; Alzheimer’s disease

ISSN:0006-8950<br/>ISSN:1460-2156<br/>Brain: A Journal of Neurology, 131 (1)<br/>